Reuters logo
BRIEF-Mirati Therapeutics presents positive data from on-going clinical trials of sitravatinib
September 14, 2017 / 8:51 PM / 2 months ago

BRIEF-Mirati Therapeutics presents positive data from on-going clinical trials of sitravatinib

Sept 15 (Reuters) - Mirati Therapeutics Inc

* Mirati Therapeutics Inc presents positive preliminary data from on-going clinical trials of sitravatinib in non-small cell lung cancer

* Mirati Therapeutics Inc - in both clinical studies, Sitravatinib alone and in combination with nivolumab was well tolerated with a manageable safety profile Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below